DocDollars

Calyxo, Inc.

CA · United States · Reporting entity ID 100000786821

Total reported 2019–2025
$2.78M
#910 of 2,960 reporting companies — 0% of all reported industry payments
$1.74M in general payments across 7,342 records, plus $1.03M in research funding across 171 records.

How it breaks down

General payments $1,741,146
Research funding $1,032,982
Ownership & investment $7,500

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Calyxo, Inc. reported $2.78M to US doctors and teaching hospitals from 2019 to 2025, ranking #910 of 2,960 reporting companies. 37% of that was research funding and 63% general payments such as consulting, speaking, food and travel. 7,342 general payment records and 171 research records were filed.

Common questions about Calyxo, Inc.

How much has Calyxo, Inc. paid US doctors?

Calyxo, Inc. reported $2,781,628 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,741,146 in general payments, $1,032,982 in research funding and $7,500 in ownership and investment interests.

How does Calyxo, Inc. rank among drug and device companies?

It ranks #910 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Calyxo, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.